Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$15.64
Net Income/Share$6.28
Operating CF/Share$3.78
Free CF/Share$3.78
Cash/Share$7.60
Book Value/Share$6.52
Tangible Book/Share$5.12
Equity/Share$6.52
Interest Debt/Share$3.80
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$651.90M
Enterprise Value$664.25M
P/E Ratio5.72P/S Ratio2.31P/OCF Ratio9.50
P/FCF Ratio9.57
P/B Ratio5.51P/TB Ratio5.51
EV/Sales2.35EV/EBITDA5.34
Graham Valuation
Graham Number$30.36
Graham Net-Net$3.16
Profitability
Earnings Yield17.49%FCF Yield10.45%ROE204.70%ROIC66.04%Return on Tangible Assets52.16%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.06%
CapEx/Revenue0.01%
CapEx/Depreciation0.02
SBC/Revenue4.27%
SG&A/Revenue0.00%
R&D/Revenue10.01%
Liquidity & Solvency
Debt/Equity0.52Debt/Assets0.25Debt/Market Cap0.09
Net Debt/EBITDA0.10
Current Ratio2.28Interest Coverage15.70xIncome Quality0.60Efficiency
Days Sales Outstanding59 days
Days Payables Outstanding72 days
Days Inventory387 days
Receivables Turnover6.14x
Payables Turnover5.06x
Inventory Turnover0.94x
Capital Structure
Tangible Assets$92.27M
Working Capital$120.53M
Invested Capital$146.97M
Intangibles/Assets10.45%